Conventional gas ventilation, liquid-assisted high-frequency oscillatory ventilation, and tidal liquid ventilation in surfactant-treated preterm lambs.
This study was designed to compare the efficacy and potential protective or injurious effects of tidal liquid ventilation (TLV), liquid-assisted high-frequency oscillatory ventilation (LA-HFOV), and high PEEP conventional mechanical ventilation (CMV) in neonatal respiratory distress syndrome. Preterm lambs (124-126 days gestation), prophylactically treated with natural surfactant, were allocated to one of the treatment modalities or to an untreated fetal control group (F), euthanised after tracheal ligation. LA-HFOV animals received an intratracheal loading dose of 5 mL x kg(-1) followed by a continuous intrapulmonary instillation of 12 mL x kg(-1);h(-1) FC-75 perfluorocarbon liquid. The ventilation strategies aimed at keeping clinically appropriate arterial blood gases for a study period of 5 hours. A histological lung injury score was calculated and semiquantitative morphometry was performed on lung tissue fixed by vascular perfusion. The alveolar-arterial pressure difference for O2 was significantly lower throughout the study in TLV compared to CMV lambs; at 1, 2, and 5 hours, oxygenation was better in TLV when compared to LA-HFOV. Total lung injury scores in TLV lambs were significantly lower than in either CMV or LA-HFOV animals, but higher when compared to F. CMV and LA-HFOV induced an excess of collapsed and overdistended alveoli, whereas in TLV alveolar expansion was normally distributed around predominantly normal alveoli. CMV and LA-HFOV, but not TLV, were associated with an excess of dilated airways. Thus, in the ovine neonatal RDS model, TLV compared favourably to either gas ventilation strategy by its more uniform ventilation, reduced lung injury, and improved gas exchange.
Degraeuwe
P L
PL
Department of Paediatrics, University Hospital Maastricht, The Netherlands. pde@skin.azm.nl
Thunnissen
F B
FB
Jansen
N J
NJ
Dormaar
J T
JT
Dohmen
L R
LR
Blanco
C E
CE
D000704:Analysis of Variance; D000818:Animals; D000831:Animals, Newborn; D004195:Disease Models, Animal; D005260:Female; D006612:High-Frequency Ventilation / Q000009:adverse effects* / Q000379:methods; D006801:Humans; D007231:Infant, Newborn; D021061:Liquid Ventilation / Q000009:adverse effects* / Q000379:methods; D008171:Lung Diseases / Q000209:etiology* / Q000401:mortality; D055370:Lung Injury; D011175:Positive-Pressure Respiration / Q000009:adverse effects* / Q000379:methods; D011247:Pregnancy; D011659:Pulmonary Gas Exchange; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy / Q000628:therapy*; D018570:Risk Assessment; D012756:Sheep; D018709:Statistics, Nonparametric; D013501:Surface-Active Agents / Q000008:administration & dosage*; D015996:Survival Rate
D013501:Surface-Active Agents